Sonrisa Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Delhi, Delhi, India, established in 2013.
2013 Delhi, Delhi, India Active
Last Updated:
Access Report
About Sonrisa Pharmaceuticals Private Limited

Sonrisa Pharmaceuticals Private Limited, a active private limited company, was established on 01 March 2013 in Delhi, Delhi, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U33100DL2013PTC248922. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Mukesh Thakur Kumar (Director), Deepak Kumar (Director). Past directors included Rita Thakur, Ritesh Kumar Thakur, Saurabh Dhingra. Its latest AGM occurred on 07 November 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No.- 112, Rg Bazar, Cs/Ocf No.-8, Sector-11, Extension Rohini, Delhi, Delhi, 110085.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100DL2013PTC248922

  • Registration Number

    248922

  • Incorporation Date

    01 March 2013

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 12 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -74.63%
  • Ebitda **** 8.08%
  • Net Worth -2.93%
  • Total Assets **** 2.37%
Company report

Sonrisa Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sonrisa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sonrisa Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mukesh Thakur Kumar Director 12 Apr 2019 Current
Deepak Kumar Director 17 Sep 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Apr 2019 Past
Pramod Abcsdd Director 17 Sep 2022 Past
Pramod Abcsdd Director 07 Dec 2014 Past
Pramod Abcsdd Director 27 Jul 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sonrisa Pharmaceuticals.

Sonrisa Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 74.63% decrease in profit. The company's net worth dipped by a decrease of 2.93%.

Sonrisa Pharmaceuticals revenue growth over time
Sonrisa Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 2.37%
*******
*******
*******
*******
Profit or Loss
*******
 -74.63%
*******
*******
*******
*******
Net Worth
*******
 -2.93%
*******
*******
*******
*******
EBITDA
*******
 8.08%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sonrisa Pharmaceuticals?

In 2017, Sonrisa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sonrisa Pharmaceuticals?

Unlock and access historical data on people associated with Sonrisa Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sonrisa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sonrisa Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sonrisa Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Sonrisa Pharmaceuticals Private Limited last Annual general meeting of members was held on 07 Nov 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Sonrisa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    Deepak Kumar was appointed as a Director was appointed as a Director on 17 Sep 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.

  • Director Appointment

    The activity Mukesh Thakur Kumar was appointed as a Director was appointed as a Director on 12 Apr 2019 & has been associated with this company since 6 years 10 months . was completed.

  • Company Incorporation

    Progress on Sonrisa Pharmaceuticals Private Limited was registered on 01 Mar 2013 with Roc Delhi & aged 12 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sonrisa Pharmaceuticals Private Limited?

The CIN of Sonrisa Pharmaceuticals Private Limited is U33100DL2013PTC248922.

Where is Sonrisa Pharmaceuticals Private Limited headquartered?

Sonrisa Pharmaceuticals Private Limited is headquartered at Unit No.- 112, Rg Bazar, Cs/Ocf No.-8, Sector-11, Extension Rohini, Delhi, Delhi, 110085.

When was Sonrisa Pharmaceuticals Private Limited incorporated?

Sonrisa Pharmaceuticals Private Limited was incorporated on 01 March 2013.

Who are the current directors of Sonrisa Pharmaceuticals Private Limited?

The current directors of Sonrisa Pharmaceuticals Private Limited are

What is the primary industry of Sonrisa Pharmaceuticals Private Limited?

The primary industry of Sonrisa Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Sonrisa Pharmaceuticals Private Limited a listed company?

Sonrisa Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sonrisa Pharmaceuticals Private Limited?

The authorized capital of Sonrisa Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Sonrisa Pharmaceuticals Private Limited?

The compliance status of Sonrisa Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available